Resultados de procura - Jenette Creaney

Limitar resultados
  1. 1
    Malignant Mesothelioma Biomarkers

    Malignant Mesothelioma Biomarkers por Jenette Creaney, B. W. Robinson

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma

    Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma por Tarek Meniawy, Jenette Creaney, Richard Lake, Anna K. Nowak

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Computational immunogenomic approaches to predict response to cancer immunotherapies

    Computational immunogenomic approaches to predict response to cancer immunotherapies por Venkateswar Addala, Felicity Newell, John V. Pearson, Alec Redwood, B. W. Robinson, Jenette Creaney, Nicola Waddell

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma

    Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma por Jenette Creaney, Deborah Yeoman, Yvonne Demelker, Amanda Segal, Arthur W. Musk, Steven J. Skates, B. W. Robinson

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo

    Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo por David W. Greening, Hong Ji, Maoshan Chen, Bruce Robinson, Ian M. Dick, Jenette Creaney, Richard J. Simpson

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    The Bloom's Syndrome Protein (BLM) Interacts with MLH1 but Is Not Required for DNA Mismatch Repair

    The Bloom's Syndrome Protein (BLM) Interacts with MLH1 but Is Not Required for DNA Mismatch Repair por Gregory T. Langland, Jennifer J. Kordich, Jenette Creaney, Kathleen H. Goss, Kate Lillard-Wetherell, Katarzyna Bębenek, Thomas A. Kunkel, Joanna Groden

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Interleukin-5 Transgenic Mice Show Enhanced Resistance to Primary Infections with<i>Nippostrongylus brasiliensis</i>but Not Primary Infections with<i>Toxocara canis</i>

    Interleukin-5 Transgenic Mice Show Enhanced Resistance to Primary Infections with<i>Nippostrongylus brasiliensis</i>but Not Primary Infections with<i>Toxocara canis</i> por Lindsay A. Dent, Christine M. Daly, Graham Mayrhofer, Trudy Zimmerman, Ann Hallett, Leon P. Bignold, Jenette Creaney, Jim C. Parsons

    Publicado 1999
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma

    Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma por Jenette Creaney, Nola Olsen, Fraser Brims, Ian M. Dick, Arthur W. Musk, Nicholas de Klerk, Steven J. Skates, B. W. Robinson

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis

    A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis por Fraser Brims, Tarek Meniawy, Ian Duffus, Duneesha de Fonseka, Amanda Segal, Jenette Creaney, Nick Maskell, Richard Lake, Nicholas de Klerk, Anna K. Nowak

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma

    Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma por Jenette Creaney, Deborah Yeoman, L. K Naumoff, Michel H. Hof, Amanda Segal, Arthur W. Musk, Nicholas de Klerk, Nora Horick, Steven J. Skates, Bruce Robinson

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma

    A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma por Anna K. Nowak, Michael Millward, Jenette Creaney, Roslyn J. Francis, Ian M. Dick, Arman Hasani, Agatha van der Schaaf, Amanda Segal, Arthur W. Musk, Michael Byrne

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies

    Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies por Shamin Li, Yannick Simoni, Summer Zhuang, Austin M. Gabel, Shaokang Ma, Jonathan Chee, Laura Islas, Anthony Cessna, Jenette Creaney, Robert K. Bradley, Alec Redwood, Bruce Robinson, Evan W. Newell

    Publicado 2021
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

    Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma por Jenette Creaney, Ian M. Dick, Tarek Meniawy, Su Lyn Leong, Justine S Leon, Yvonne Demelker, Amanda Segal, Arthur W. Musk, Gary Lee, Steven J. Skates, Anna K. Nowak, B. W. Robinson

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma

    Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma por Anders Hjerpe, Valeria Ascoli, Carlos Bedrossian, Mathilde E. Boon, Jenette Creaney, Ben Davidson, Annika Dejmek, Katalin Dobra, Ambrogio Fassina, Andrew Field, Pınar Firat, Toshiaki Kamei, Tadao K. Kobayashi, Claire W. Michael, Sevgen Önder, Amanda Segal, Philippe Vielh

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology

    Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endor... por Anders Hjerpe, Valeria Ascoli, Carlos Bedrossian, Mathilde E. Boon, Jenette Creaney, Ben Davidson, Annika Dejmek, Katalin Dobra, Ambrogio Fassina, Andrew Field, Pınar Firat, Toshiaki Kamei, Tadao K. Kobayashi, Claire W. Michael, Sevgen Önder, Amanda Segal, Philippe Vielh

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study

    BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study por Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk, Christos Meristoudis, Siaw Ming Chai, Chris Van Vliet, Gary Lee, Ian M. Dick, Tina Firth, Louise Andersen Lynggaard, Azadeh Birbaneh Asghari, Mogens Vyberg, Johnni Hansen, Jenette Creaney, Oluf Dimitri Røe

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma

    Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma por Michaela B. Kirschner, Yuen Yee Cheng, Bahareh Badrian, Steven Kao, Jenette Creaney, J. James Edelman, Nicola J. Armstrong, Michael P. Vallely, Arthur W. Musk, B. W. Robinson, Brian C. McCaughan, Sonja Klebe, Steven E. Mutsaers, Nico van Zandwijk, Glen Reid

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma por Matthew J. Bott, Marie Brevet, Barry S. Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard Lake, Maureen F. Zakowski, Boris Reva, Chris Sander, Robert Delsite, Simon N. Powell, Qin Zhou, Ronglai Shen, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis

    Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis por Kevin Hollevoet, Johannes B. Reitsma, Jenette Creaney, Bogdan Grigoriu, Bruce Robinson, Arnaud Scherpereel, Alfonso Cristaudo, Harvey I. Pass, Kristiaan Nackaerts, José Antonio Rodríguez Portal, Joachim Schneider, Thomas Muley, Francesca Di Serio, Paul Baas, Marco Tomasetti, J. Alex, Jan P. van Meerbeeck

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing

    Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing por Ann‐Marie Patch, Kátia Nones, Stephen H. Kazakoff, Felicity Newell, Scott Wood, Conrad Leonard, Oliver Holmes, Qinying Xu, Venkateswar Addala, Jenette Creaney, B. W. Robinson, Shujin Fu, Chunyu Geng, Tong Li, Wenwei Zhang, Xinming Liang, Junhua Rao, Jiahao Wang, Mingyu Tian, Yonggang Zhao, Fei Teng, Honglan Gou, Bicheng Yang, Hui Jiang, Feng Mu, John V. Pearson, Nicola Waddell

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: